相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Blockade of Glutathione Metabolism in IDH1-Mutated Glioma
Xiaoying Tang et al.
MOLECULAR CANCER THERAPEUTICS (2020)
Targeting IDH1-Mutated Malignancies with NRF2 Blockade
Yang Liu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Pheochromocytomas and Paragangliomas: From Genetic Diversity to Targeted Therapies
Ying Pang et al.
CANCERS (2019)
Brusatol, an NRF2 inhibitor for future cancer therapeutic
Sabrina J. Cai et al.
CELL AND BIOSCIENCE (2019)
Telomerase Activation and ATRX Mutations Are Independent Risk Factors for Metastatic Pheochromocytoma and Paraganglioma
Sylvie Job et al.
CLINICAL CANCER RESEARCH (2019)
Targeting NAD+/PARP DNA Repair Pathway as a Novel Therapeutic Approach to SDHB-Mutated Cluster I Pheochromocytoma and Paraganglioma
Ying Pang et al.
CLINICAL CANCER RESEARCH (2018)
Krebs-cycle-deficient hereditary cancer syndromes are defined by defects in homologous-recombination DNA repair
Parker L. Sulkowski et al.
NATURE GENETICS (2018)
Alternative assembly of respiratory complex II connects energy stress to metabolic checkpoints
Ayenachew Bezawork-Geleta et al.
NATURE COMMUNICATIONS (2018)
New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification
Joakim Crona et al.
ENDOCRINE REVIEWS (2017)
Exploring brusatol as a new anti-pancreatic cancer adjuvant: biological evaluation and mechanistic studies
Zheng Lu et al.
ONCOTARGET (2017)
Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway
Pang Ying et al.
ONCOTARGET (2017)
Evaluating In Vitro DNA Damage Using Comet Assay
Yanxin Lu et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2017)
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
Lauren Fishbein et al.
CANCER CELL (2017)
CHARACTERISTICS AND OUTCOMES OF METASTATIC SDHB AND SPORADIC PHEOCHROMOCYTOMA/PARAGANGLIOMA: AN NATIONAL INSTITUTES OF HEALTH STUDY
Hana Turkova et al.
ENDOCRINE PRACTICE (2016)
ROS homeostasis and metabolism: a dangerous liason in cancer cells
E. Panieri et al.
CELL DEATH & DISEASE (2016)
Brusatol Enhances the Radiosensitivity of A549 Cells by Promoting ROS Production and Enhancing DNA Damage
Xiaohui Sun et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity-implications for therapeutic targeting of Nrf2
Adedamola Olayanju et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Mutant glucocerebrosidase in Gaucher disease recruits Hsp27 to the Hsp90 chaperone complex for proteasomal degradation
Chunzhang Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas
Luis Jaime Castro-Vega et al.
NATURE COMMUNICATIONS (2015)
Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas
Lauren Fishbein et al.
NATURE COMMUNICATIONS (2015)
HMGB1 facilitates repair of mitochondrial DNA damage and extends the lifespan of mutant ataxin-1 knock-in mice
Hikaru Ito et al.
EMBO MOLECULAR MEDICINE (2015)
Free radicals, reactive oxygen species, oxidative stress and its classification
Volodymyr I. Lushchak
CHEMICO-BIOLOGICAL INTERACTIONS (2014)
Chemotherapy with cyclophosphamide, vincristine and dacarbazine for malignant paraganglioma and pheochromocytoma: systematic review and meta-analysis
N. D. Niemeijer et al.
CLINICAL ENDOCRINOLOGY (2014)
SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma
Julien Hadoux et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity
Patricia L. M. Dahia
NATURE REVIEWS CANCER (2014)
Novel HIF2A mutations disrupt oxygen sensing, leading to polycythemia, paragangliomas, and somatostatinomas
Chunzhang Yang et al.
BLOOD (2013)
The emerging role of the Nrf2-Keap1 signaling pathway in cancer
Melba C. Jaramillo et al.
GENES & DEVELOPMENT (2013)
Hypoxia-Inducible Factor Signaling in Pheochromocytoma: Turning the Rudder in the Right Direction
Ivana Jochmanova et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Progenitor Cell Line (hPheo1) Derived from a Human Pheochromocytoma Tumor
Hans K. Ghayee et al.
PLOS ONE (2013)
Genomic instability induced by mutant succinate dehydrogenase subunit D (SDHD) is mediated by O2-° and H2O2
Kjerstin M. Owens et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Mitochondrial Complex II Can Generate Reactive Oxygen Species at High Rates in Both the Forward and Reverse Reactions
Casey L. Quinlan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
NRF2 and cancer: the good, the bad and the importance of context
Michael B. Sporn et al.
NATURE REVIEWS CANCER (2012)
Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma
Nelly Burnichon et al.
HUMAN MOLECULAR GENETICS (2011)
Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism
Dongmei Ren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Survival of Patients with Metastatic Malignant Pheochromocytoma and Efficacy of Combined Cyclophosphamide, Vincristine, and Dacarbazine Chemotherapy
Kaoru Nomura et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Treatment of Malignant Pheochromocytoma/Paraganglioma With Cyclophosphamide, Vincristine, and Dacarbazine Recommendation From a 22-Year Follow-up of 18 Patients
Hui Huang et al.
CANCER (2008)
Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth
Tsutonm Ohta et al.
CANCER RESEARCH (2008)
Germline SDHB mutations and familial renal cell carcinoma
Christopher Ricketts et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Loss of the SdhB, but not the SdhA subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis
Robert D. Guzy et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1
Birke Bausch et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Genetic testing in pheochromocytoma or functional paraganglioma
L Amar et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations
HPH Neumann et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations (vol 292, pg 943, 2004)
HPH Neumann
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Architecture of succinate dehydrogenase and reactive oxygen species generation
V Yankovskaya et al.
SCIENCE (2003)
Germ-line mutations in nonsyndromic pheochromocytoma.
HPH Neumann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
分享论文
